New studies indicate Paxlovid does not relieve long COVID symptoms im adults or prevent condition in teenagers
Submitted by mike kraft on

A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.
..
Country / Region Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -